Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | VIKING THERAPEUTICS INC | NASDAQ | Biotechnology | $3.34B | $28.75 | 0.49% | -$471.93M | -6.93x | 0.21 | United States | ||
| EQT | EQT CORP | NYSE | Oil & Gas E&P | $32.49B | $51.94 | 1.45% | $7.34B | 9.76x | 0.51 | United States | ||
| BNTX | BIONTECH SE | NASDAQ | Biotechnology | $21.73B | $90.54 | 1.12% | -$781.88M | -15.18x | 0.13 | Germany | ||
| SLDB | SOLID BIOSCIENCES INC | NASDAQ | Biotechnology | $702.93M | $7.14 | -1.11% | -$187.75M | -3.66x | 0.13 | United States | ||
| PCVX | VAXCYTE INC | NASDAQ | Biotechnology | $6.85B | $47.46 | 0.36% | -$920.69M | -6.90x | 0.12 | United States | ||
| CGEM | CULLINAN THERAPEUTICS INC | NASDAQ | Biotechnology | $841.98M | $13.70 | 5.55% | -$220.73M | -4.07x | 0.10 | United States | ||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | NASDAQ | Capital Markets | $997.52M | $3.73 | -1.58% | $31.63M | -5.65x | 0.21 | Canada | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | NYSEMKT | Medical Devices | $336.44M | $2.95 | -0.67% | -$107.93M | -2.11x | 0.18 | United States | ||
| ODTX | ODYSSEY THERAPEUTICS INC | NASDAQ | Biotechnology | N/A | $16.90 | 0.54% | -$144.65M | -0.35x | -0.11 | United States | ||
| KLRA | KAILERA THERAPEUTICS INC | NASDAQ | Biotechnology | $2.45B | $18.89 | -3.33% | N/A | N/A | -0.15 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.